Марина Тарасова: Принципы индивидуального выбора гормональной заместительной терапии в пери– и постменопаузе

19. Long-term low-dose dehydroepiandrosterone oral supplementation in early and late postmenopausal women modulates endocrine parameters and synthesis of neuroactive steroids / Genazzani A. D., Stomati М., Bernardi F., Pieri М., Rovati L., Genaz-zani A. R. // Fertil Steril. – 2003. – Vol. 80 (6) – P. 1495–1501.

20. Management of hormone replacement therapy: the Swedish experience / Mattson L., Stadberg E., Milson I. // Eur. J. Obstet. Gynecol. Reprod. Biol. – 1996. – 64 (Suppl 1): S3-S5.

21. Management of menopause– associated vasomotor symptoms: current treatment options, challenges and future directions / Pachman D. R, Jones J. M, Loprinzi C. L. // International Journal of Wolmen’s Health. – 2010. – Vol. 2. – P. 123–135.

22. Might DHEA be considered a beneficial replacement therapy in the elderly? / Genazzani A. D., Lanzoni C., Genazzani A. R. // Drugs Aging. – 2007. – 24 (3). – P. 173–185.

23. Palacios S. SERMs, an update. 6th Amsterdam menopause and women’s health symposium: Abstracts [Amsterdam], – 2010. – P.39.

24. Postmenopausal hormone therapy: An Endocrine Society Scientific Statement / Sant-en R. J, Allred D. C., Ardoin S. P, Archer D. F., Boyd N. et al. // The Journal of Clinical Endocrinology & Metabolism. – 2010. – Vol. 95, Supplement 1 – S1-66.

25. Rice S. Whitehead etanolic extracts of black cohosh (Acetaea racemosa) inhibit growth and oestradiol synthesis from oestron sulphate in breast cancer cells / Rice S., Amon A. // Maturitas. – 2007. – Vol.56. P. 359–367.

26. Shen W. Treatment strategies for hot flushes. / Shen W, Stearns V. // Expert. Opin. Phar-macother. – 2009. – Vol. 10 (7). – P. 1133–1144.

27. Simon J. S. WHI revisited after 8 years. Relevance to today s practice 6th Amsterdam menopause and women’s health symposium: Abstracts [Amsterdam], – 2010. – P. 68.

28. Six-months oral dehydroepiandrosterone supplementation in early and late postmenopause / Stomati М., Monteleone P., Casarosa E., Quirici B., Puccetti S., Bernardi F., Genazzani A. D., Rovati L., Luisi М., Genazzani A. R. // Gynecological Endocrinology. – 2000. – Vol. 14 – P. 342–363.

29. Speroff L. Estetrol – an unique estrogen. 6th Amsterdam menopause and women’s health symposium: Abstracts [Amsterdam], – 2010. – P.61.

30. StanczykF. Z. Pharmacokinetics and potency of progestins used for hormone replacement therapy and contraception // Reviews in endocrine & metabolic disorders. – 2002 – Vol. 3. – P. 211–224.

31. The Cimicifuga preparation BNO 1055 vs conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers / Wutt-ke W., Seidova-Wuttke D., Gorkow C. // Maturitas 2003. – 44: Suppl 1: 67–77.

32. Updated practical recommendations for hormone replacement therapy in the peri– and postmenopause / Birkh user М. H., Panay N., Archer D. F., Barlow D, Burger H, Gam-bacciani М., Goldstein S., Pinkerton J. A., Sturdee D. W. // Climacteric. – 2008. – Vol. 11, —P. 108–123.

33. Use of hormone replacement therapy in Washington State. Is prevention being put into practice? / Saver B., Taylor Т., Woods N. // J. Family Pract. – 1999. – 48. – P. 364–371.

34. Use of hormone replacement therapy: women\'s representation of menopause and beauty care practices. / Fauconnier A., Ringa V., Delanoe D., Falissard B., Breart G. // Maturitas. – 2000. – Vol. 35. – P. 215–228.

35. Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS) / Miller V. М., Black D. М., Brinton E. A., Budoff M. J., Cedars М. I. et al. // J Cardiovasc. Transl. Res. – 2009 – Vol. 2(3) – P. 228–239.

36. Why menopausal women do not want to take hormone replacement therapy / Rabin D. S., Cipparrone N., Linn E. S., Moen M. // Menopause. – 1999. – Vol.6. – P. 61–67.

37. Women and menopause: beliefs, attitudes, and behaviors. The North American Menopause Society 1997 menopause survey. / Kaufert P., Boggs P.P., Ettinger B., Woods N. F., Utian W. H. // Menopause. – 1998. – Vol. 5. – P. 197–202.

38. Women\'s Health in Lund Area (WHILA) Study. Impotant Factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women\'s Health in Lund Area (WHILA) Study. / Li C., Samsioe G., Lidfelt J., Nerbrand C., Agardh C. D. // Menopause. – 2000. – Vol. 7. – P. 273–281.

39. Women\'s knowledge of hormone therapy / Coo H., O\'Connor K. S., Hunter D. // Patient. Educ. Counsel. – 2001. – Vol.45. – P. 295–301.

40. www.sensus.gov World Population. 2008.

Бланк заказа литературы ООО «Издательство H-Л»(812) 784-97-51,nl@n-l.ru

По ценам издательства пособия можно приобрести: в ООО

«Издательство Н-Л» по адресу: Санкт-Петербург, ул. Автовская, д. 17,

1 – й этаж. Пн. – пт.: с 10до 18, Телефон: (812) 784-97-51